Skip to main content

MoneyWorks4Me

Advanced Enzymes completes acquisition of additional 1.22% stake in JC Biotech

19 Nov 2026 Evaluate

Advanced Enzymes Technologies has completed the acquisition of additional stake of 1.22% in JC Biotech, subsidiary (JCB) by way of purchase of 2,53,297 Equity Shares from few selling shareholders of JCB, for a consideration of Rs 2.28 crore i.e. Rs 90 per Equity Share. In view of this, the shareholding of the company in JCB has increased from 95.72% to 96.94% of paid-up share capital of JCB effective from November 18, 2026. 

Further, the company is in the process of acquiring the remaining 3.06% equity stake in JCB. Upon completion of the said acquisition, JCB will become a Wholly Owned Subsidiary of the Company. 

Advanced Enzymes Technologies is a research driven company with global leadership in manufacturing of enzymes and probiotics. It is the largest Indian enzyme company engaged in the research and development, manufacturing and marketing of vast proprietary products developed from many indigenous enzymes & probiotics.


Peers
Company Name CMP
Sun Pharma. Inds. 1885.10
Dr. Reddys Labs. 1390.50
Cipla 1414.95
Lupin 2010.00
Zydus Lifesciences 1195.05
View more..